PK time points [Design Issues]

posted by dshah  – India/United Kingdom, 2022-06-24 13:29 (728 d 06:25 ago) – Posting: # 23078
Views: 1,366

Dear Vaibhav!

❝ 2, 12 and 24 hrs after administration. Additional samples were collected on day 2, 4, 6, 8, 10, 14, 28, 42, 56, 84, 112 and 140 days.


I believe that addition of 6 hrs and 12 days would be helpful.
The method of administration would be also critical for impact on burst release.
What is your Cmax and LLOQ-ULOQ?
Regards,
Divyen Shah

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,664 registered users;
37 visitors (0 registered, 37 guests [including 4 identified bots]).
Forum time: 19:54 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5